{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:26:41Z","timestamp":1775910401795,"version":"3.50.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL006119"],"award-info":[{"award-number":["HL006119"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>AMP-activated protein kinase (AMPK) is an evolutionarily conserved energy sensor. Activation of AMPK leads to a number of metabolic benefits, including improved mitochondrial function in skeletal muscle and lowering of serum glucose levels in type-2 diabetes models. However, direct activation of AMPK leads to cardiac enlargement, and an alternative strategy that activates AMPK without affecting the heart is needed. Inhibition of phosphodiesterase 4 (PDE4), which is poorly expressed in the human heart, activates AMPK in other tissues. In a screen to identify novel PDE4 inhibitors, we discovered compound CBU91, which is 5\u201310 fold more potent than rolipram, the best characterized PDE4 inhibitor. CBU91, like rolipram, is able to activate AMPK and Sirt1 and increase mitochondrial function in myotubes. These findings suggest that activation of AMPK in myotubes is a general property of PDE4 inhibition and that PDE4 inhibition may activate AMPK in metabolically relevant tissues without affecting the heart.<\/jats:p>","DOI":"10.1371\/journal.pone.0253269","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T17:36:45Z","timestamp":1623951405000},"page":"e0253269","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6935-569X","authenticated-orcid":true,"given":"Sung-Jun","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4242-2941","authenticated-orcid":true,"given":"Faiyaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Bahde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Philp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1695-9630","authenticated-orcid":true,"given":"Jeonghan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7988-6921","authenticated-orcid":true,"given":"William C.","family":"Trenkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay H.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"issue":"4","key":"pone.0253269.ref001","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"DH Maurice","year":"2014","journal-title":"Nature reviews Drug discovery"},{"issue":"3","key":"pone.0253269.ref002","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/brv.12020","article-title":"Biological roles of cAMP: variations on a theme in the different kingdoms of life","volume":"88","author":"JM Gancedo","year":"2013","journal-title":"Biological reviews of the Cambridge Philosophical Society"},{"issue":"1","key":"pone.0253269.ref003","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00555.2011","article-title":"cAMP signaling in skeletal muscle adaptation: hypertrophy, metabolism, and regeneration","volume":"303","author":"R Berdeaux","year":"2012","journal-title":"American journal of physiology Endocrinology and metabolism"},{"issue":"5","key":"pone.0253269.ref004","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments","volume":"165","author":"T Keravis","year":"2012","journal-title":"British journal of pharmacology"},{"issue":"8","key":"pone.0253269.ref005","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1517\/13543776.2013.794789","article-title":"Phosphodiesterase-4 inhibitors: a review of current developments (2010\u20132012)","volume":"23","author":"A Gavalda","year":"2013","journal-title":"Expert opinion on therapeutic patents"},{"issue":"11","key":"pone.0253269.ref006","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1517\/13543770903313753","article-title":"PDE4 inhibitors: a review of current developments (2005\u20132009)","volume":"19","author":"L Pages","year":"2009","journal-title":"Expert opinion on therapeutic patents"},{"issue":"9","key":"pone.0253269.ref007","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1517\/14728222.2013.818656","article-title":"PDE4 as a target for cognition enhancement","volume":"17","author":"W Richter","year":"2013","journal-title":"Expert opinion on therapeutic targets"},{"issue":"11","key":"pone.0253269.ref008","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/npp.2009.66","article-title":"Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus","volume":"34","author":"YF Li","year":"2009","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"issue":"7","key":"pone.0253269.ref009","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/bph.12189","article-title":"Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1","volume":"169","author":"R Korhonen","year":"2013","journal-title":"British journal of pharmacology"},{"key":"pone.0253269.ref010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4137\/CCRPM.S7049","article-title":"Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations","volume":"5","author":"SK Field","year":"2011","journal-title":"Clinical medicine insights Circulatory, respiratory and pulmonary medicine"},{"issue":"8","key":"pone.0253269.ref011","doi-asserted-by":"crossref","first-page":"E1476","DOI":"10.1210\/jc.2014-1430","article-title":"Phosphodiesterase 4 inhibition as a potential new therapeutic target in obese women with polycystic ovary syndrome","volume":"99","author":"M Jensterle","year":"2014","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"10","key":"pone.0253269.ref012","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00125-012-2632-z","article-title":"The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db\/db mice","volume":"55","author":"S Vollert","year":"2012","journal-title":"Diabetologia"},{"issue":"9","key":"pone.0253269.ref013","doi-asserted-by":"crossref","first-page":"E1720","DOI":"10.1210\/jc.2011-2886","article-title":"Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus","volume":"97","author":"EF Wouters","year":"2012","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"3","key":"pone.0253269.ref014","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","article-title":"Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases","volume":"148","author":"SJ Park","year":"2012","journal-title":"Cell"},{"issue":"4","key":"pone.0253269.ref015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/adip.21158","article-title":"Metabolic benefits of inhibiting cAMP-PDEs with resveratrol","volume":"1","author":"JH Chung","year":"2012","journal-title":"Adipocyte"},{"issue":"4","key":"pone.0253269.ref016","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bbrc.2014.07.039","article-title":"Calorie restriction mimicking effects of roflumilast prevents diabetic nephropathy","volume":"450","author":"K Tikoo","year":"2014","journal-title":"Biochemical and biophysical research communications"},{"issue":"19","key":"pone.0253269.ref017","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1016\/j.bmcl.2010.08.021","article-title":"Synthesis and evaluation of 1,2,4-triazolo[1,5-c]pyrimidine derivatives as A2A receptor-selective antagonists","volume":"20","author":"BA Shinkre","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"pone.0253269.ref018","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/MCB.18.3.1416","article-title":"Physiological phosphorylation of protein kinase A at Thr-197 is by a protein kinase A kinase","volume":"18","author":"RD Cauthron","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"7241","key":"pone.0253269.ref019","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"C Cant\u00f3","year":"2009","journal-title":"Nature"},{"issue":"1","key":"pone.0253269.ref020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Z Wu","year":"1999","journal-title":"Cell"},{"issue":"12","key":"pone.0253269.ref021","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1073\/pnas.1232352100","article-title":"An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle","volume":"100","author":"C Handschin","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"29","key":"pone.0253269.ref022","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1073\/pnas.0705070104","article-title":"AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha","volume":"104","author":"S J\u00e4ger","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"pone.0253269.ref023","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-981-15-0602-4_19","article-title":"Autophagy in Mitochondrial Quality Control","volume":"1206","author":"R Wang","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"6016","key":"pone.0253269.ref024","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.1196371","article-title":"Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy","volume":"331","author":"DF Egan","year":"2011","journal-title":"Science"},{"issue":"37","key":"pone.0253269.ref025","doi-asserted-by":"crossref","first-page":"22352","DOI":"10.1074\/jbc.M115.667345","article-title":"Apoptotic cells activate AMP-activated protein kinase (AMPK) and inhibit epithelial cell growth without change in intracellular energy stores","volume":"290","author":"VA Patel","year":"2015","journal-title":"J Biol Chem"},{"issue":"7","key":"pone.0253269.ref026","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI40671","article-title":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state","volume":"120","author":"M Foretz","year":"2010","journal-title":"J Clin Invest"},{"issue":"6350","key":"pone.0253269.ref027","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1126\/science.aah5582","article-title":"Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy","volume":"357","author":"RW Myers","year":"2017","journal-title":"Science"},{"issue":"1","key":"pone.0253269.ref028","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/s41598-017-02455-z","article-title":"A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation","volume":"7","author":"KQ Yang","year":"2017","journal-title":"Sci Rep"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0253269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T17:37:23Z","timestamp":1623951443000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0253269"}},"subtitle":[],"editor":[{"given":"Ping","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0253269","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]}}}